0 0.5 1 1.5+ All studies 7% 4 2,143 Improvement, Studies, Patients Relative Risk Mortality 27% 1 1,949 ICU admission -200% 1 14 Hospitalization 25% 4 2,143 Viral clearance 44% 3 193 RCTs 7% 4 2,143 Early 17% 3 2,129 Late -200% 1 14 Peginterferon Lambda for COVID-19 c19early.org October 2023 Favorspeg.. lambda Favorscontrol